 PARSIPPANY, N.J., Aug. 05, 2020 GLOBE NEWSWIRE -- Pacira BioSciences, Inc. NASDAQ: PCRX today announced that it will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference at 9:10 AM ET on Tuesday, August 11, 2020. Live audio of the virtual event can be accessed by visiting the Events page of the companys website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event. About Pacira Pacira BioSciences, Inc. NASDAQ: PCRX is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The companys long-acting local analgesic, EXPAREL bupivacaine liposome injectable suspension was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, the company acquired the iovera0 system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit Contact: Pacira BioSciences, Inc. Christian Pedetti 973 254-4387 